The investment round was oversubscribed and was led by DFJ ePlanet Ventures with participation from existing corporate investor ResMed. BiancaMed, whose target markets are the fast growing mobile and home-health sectors, was founded in 2003 and is based in NovaUCD, the Innovation and Technology Transfer Centre at UCD.
BiancaMed, whose vision is to provide easy-to-use mobile phone and home based wellness and health monitoring technologies and services for use in daily life, was co-founded by Dr Philip de Chazal, Dr Conor Hanley and Professor Conor Heneghan as a spin-off from UCD’s School of Electrical, Electronic and Mechanical Engineering.
Speaking about the investment, Dr Conor Hanley, CEO said, “BiancaMed is delighted to have secured this significant investment from such a prestigious global investor, with a proven track record in growing successful medical technology companies. BiancaMed is also delighted to welcome Dennis Atkinson and Donald Fitzmaurice to the Board.” He added, “The money raised will be used to accelerate our technology development and our entry into rapidly growing markets that are expected to be very large.”
Increasingly stressful lifestyles, a rise in chronic diseases and obesity and an aging population are directly contributing to skyrocketing health care costs. BiancaMed is providing mobile phone and home based solutions that empower individuals and patients to better manage their wellbeing and health. In short, BiancaMed aims to transform wellbeing and health by providing the ultimate convenience in personal health monitoring.
At the core of BiancaMed’s product platform is a very sensitive motion sensor that detects heart rate and respiration - without having to touch a person - completely wirelessly. The sensor, combined with the company's sophisticated health analysis software, provides solutions to monitor sleep, diet and exercise - the three elements of wellbeing. The company's product line, initially including baby, home health and exercise monitors, will ultimately be converged with the convenience and ease of a mobile phone.
Donald Fitzmaurice of DFJ ePlanet Ventures speaking about the investment said, “We are very excited about BiancaMed and are looking forward to working closely with the founders and management to grow a successful company. Furthermore, all the ingredients for success are present: a major opportunity in personalised healthcare, a visionary and experienced team and a proven ability to innovate clinically at the outset.”
Dr Pat Frain, Director, NovaUCD speaking about the investment said, “A major priority for UCD is the commercialisation of its research through a combination of licensing and the formation of spin-out companies. BiancaMed is an excellent example of a start-up company which was established to commercialise UCD intellectual property created by the founders of BiancaMed.” He added, “This investment demonstrates that university spin-outs, such as BiancaMed with strong intellectual property and cutting-edge technology continue to have the potential to attract significant investment to implement their business development plans.”
Miceal Whelan | alfa
Virtual Reality in Medicine: New Opportunities for Diagnostics and Surgical Planning
07.12.2016 | Universität Basel
3-D printed kidney phantoms aid nuclear medicine dosing calibration
06.12.2016 | Society of Nuclear Medicine
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine